Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-73.85%
operating margin TTM
-50.85%
revenue TTM
7.62 Million
revenue per share TTM
1.31$
valuation ratios | |
|---|---|
| pe ratio | -0.30 |
| peg ratio | -0.00 |
| price to book ratio | -16.53 |
| price to sales ratio | 0.36 |
| enterprise value multiple | -0.36 |
| price fair value | -16.53 |
profitability ratios | |
|---|---|
| gross profit margin | 66.26% |
| operating profit margin | -50.85% |
| pretax profit margin | -83.99% |
| net profit margin | -73.85% |
| return on assets | -211.01% |
| return on equity | -5944.86% |
| return on capital employed | -857.59% |
liquidity ratio | |
|---|---|
| current ratio | 0.68 |
| quick ratio | 0.41 |
| cash ratio | 0.15 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 84.61 |
| operating cycle | 99.13 |
| days of payables outstanding | 68.91 |
| cash conversion cycle | 30.22 |
| receivables turnover | 25.14 |
| payables turnover | 5.30 |
| inventory turnover | 4.31 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.49 |
| debt equity ratio | -12.96 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 1.08 |
| interest coverage | -5.50 |
| cash flow to debt ratio | -3.10 |
cash flow ratios | |
|---|---|
| free cash flow per share | -1.46 |
| cash per share | 0.12 |
| operating cash flow per share | -1.46 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | -3.10 |
| short term coverage ratios | -9.17 |
| capital expenditure coverage ratio | -863.83 |
Frequently Asked Questions
When was the last time NovaBay Pharmaceuticals, Inc. (AMEX:NBY) reported earnings?
NovaBay Pharmaceuticals, Inc. (NBY) published its most recent earnings results on 07-11-2024.
What is NovaBay Pharmaceuticals, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. NovaBay Pharmaceuticals, Inc. (AMEX:NBY)'s trailing twelve months ROE is -5944.86%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. NovaBay Pharmaceuticals, Inc. (NBY) currently has a ROA of -211.01%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did NBY's net profit margin stand at?
NBY reported a profit margin of -73.85% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is NBY's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 0.68 in the most recent quarter. The quick ratio stood at 0.41, with a Debt/Eq ratio of -12.96.